Meropenem Injection

Injections · Powder for Injection · 500mg / 1g

Trade Information

Minimum Order Qty	500,000 vials
Capacity	50 Million Vials per month
Strength	500mg / 1g
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Single vial pack
Tray pack
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Meropenem (as Trihydrate)
Dosage Form	Powder for Injection
Pack Size	Vial / Tray pack / Custom packing available
Storage	Store below 25°C in a dry place, protected from light
Shelf Life	24 months from date of manufacture

Description

Meropenem is a broad-spectrum carbapenem antibiotic used in hospitals for serious and resistant bacterial infections. It is a critical reserve medicine for intensive care and is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Meropenem injection in 500mg and 1g presentations, supplied principally through hospital and institutional tender channels. As a carbapenem, responsible stewardship is important, and we support institutional buyers with reliable, quality-assured supply for critical care continuity.

Mechanism of Action

Meropenem is a carbapenem antibiotic that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. It has one of the broadest spectra of any antibiotic, covering Gram-positive, Gram-negative, and anaerobic organisms, and is highly stable against most beta-lactamase enzymes. This makes it a reserve agent for serious and multi-drug-resistant infections where narrower antibiotics are unsuitable. As a reserve antibiotic, it is used under stewardship-conscious hospital protocols.

Indications

Hospital-acquired and severe pneumonia
Complicated intra-abdominal infections
Complicated urinary tract infections
Sepsis and bloodstream infections
Bacterial meningitis
Multi-drug-resistant Gram-negative infections

Available Variants

Meropenem Injection 500mg
Meropenem Injection 1g

Frequently Asked Questions

What is Meropenem used for?

Meropenem is a broad-spectrum carbapenem antibiotic used in hospitals for serious infections including hospital-acquired pneumonia, complicated intra-abdominal and urinary infections, sepsis, meningitis, and multi-drug-resistant infections. It is a reserve antibiotic for critical care.

What presentations of Meropenem does BioGalen manufacture?

BioGalen manufactures Meropenem injection in 500 mg and 1 g presentations as powder for reconstitution, under WHO-GMP with CTD and ACTD dossiers available.

Does BioGalen supply Meropenem for hospital tenders?

Yes. BioGalen supplies WHO-GMP Meropenem to hospitals, tender suppliers, and national procurement programmes, supporting dependable access to reserve injectable antibiotics for critical care.

Explore More

Interested in Meropenem Injection?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form